31.17
Doximity Inc stock is traded at $31.17, with a volume of 1.13M.
It is up +4.18% in the last 24 hours and up +20.77% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$29.92
Open:
$29.75
24h Volume:
1.13M
Relative Volume:
0.34
Market Cap:
$5.56B
Revenue:
$644.86M
Net Income/Loss:
$196.05M
P/E Ratio:
31.77
EPS:
0.9812
Net Cash Flow:
$317.50M
1W Performance:
+6.09%
1M Performance:
+20.77%
6M Performance:
+30.42%
1Y Performance:
-54.20%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
31.17 | 5.56B | 644.86M | 196.05M | 317.50M | 0.9812 |
|
VEEV
Veeva Systems Inc
|
311.10 | 50.37B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.19 | 12.74B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.04 | 12.28B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.36 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.47 | 7.65B | 1.34B | 230.70M | 440.96M | 2.6695 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-10-26 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jun-29-26 | Downgrade | BofA Securities | Buy → Underperform |
| May-15-26 | Downgrade | Barclays | Overweight → Equal Weight |
| May-14-26 | Downgrade | BTIG Research | Buy → Neutral |
| May-14-26 | Downgrade | Jefferies | Buy → Hold |
| May-14-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-14-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-14-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research
רוזן, משפטן מדורג מוביל גלובלי, מעודד את משקיעי Doximity, Inc לגייס ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – DOCS - GlobeNewswire Inc.
Sprout Social Investor News: If You Own Stock in Sprout Social, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. LawsuitDOCS - FinancialContent
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 16, 2026 Against Doximity, Inc. (NYSE: DOCS) - Barchart.com
Is Doximity (DOCS) Below Fair Value Following The AI Spending Surge? - Yahoo Finance
Reflecting On Vertical Software Stocks’ Q2 Earnings: Doximity (NYSE:DOCS) - TradingView
A Look at Doximity Inc (DOCS) After 6.1% Gain -- GF Value $45.93 vs Price $29.38 - GuruFocus
Palantir Technologies, Doximity, Snowflake, and Teradata Shares Skyrocket, What You Need To Know - Yahoo Finance
DOCS ALERT: Bragar Eagel & Squire, P.C. Reminds Doximity, - GlobeNewswire
SueWallSt Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026DOCS - Morningstar
SueWallSt Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026DOCS - PR Newswire
SueWallSt Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026DOCS - TradingView
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost - GlobeNewswire
DEADLINE ALERT for BETR, DOCS, BIDU, UWMC: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
DOCS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
DOCS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities LawsuitContact Levi & Korsinsky - PR Newswire
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Insider Selling: Doximity (NYSE:DOCS) Director Sells 2,000 Shares of Company Stock - MarketBeat
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance UK
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Kaplan Fox Encourages Doximity, Inc. (NYSE: DOCS) Investors Seeki - The National Law Review
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost - GlobeNewswire
DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesNovember 16, 2026 Deadline - The Daily Tribune News
DOCS INVESTOR NOTICE: Doximity, Inc. Investors with - GlobeNewswire
DOCS Investor Alert: Doximity, Inc. Securities Class Action NoticeContact Levi & Korsinsky - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Reasons to Retain Doximity Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Doximity Stock in Your Portfolio for Now - TradingView
Reasons to Retain Doximity Stock in Your Portfolio for Now - TradingView
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit - The Transylvania Times
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
2,000 Doximity (DOCS) shares worth $57,820 are in director Kira Wampler's proposed sale. - Stock Titan
Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
DOCS Deadline Alert: SueWallSt Reminds Doximity, Inc. (DOCS) Investors of Securities Class Action Deadline on November 16, 2026 - PR Newswire
רוזן, משרד עורכי דין מוביל, קורא למשקיעי חברת Doximity, Inc לשכור ייצוג משפטי לקראת מועד אחרון חשוב במסגרת תביעה ייצוגית בניירות הערך – DOCS - GlobeNewswire Inc.
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.
ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity, - GlobeNewswire
UiPath, monday.com, Amplitude, Doximity, and Sprinklr Shares Skyrocket, What You Need To Know - Yahoo Finance
DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
Doximity (DOCS) Gains As Market Dips: What You Should Know - Zacks Investment Research
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Doximity Inc Stock (DOCS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wampler Kira Scherer | Director |
Oct 01 '26 |
Sale |
28.91 |
2,000 |
57,820 |
27,923 |
| KIRA WAMPLER | Director |
Oct 01 '26 |
Proposed Sale |
28.91 |
2,000 |
57,820 |
0 |
| PHOEBE L YANG WATKIN | Director |
Sep 30 '26 |
Proposed Sale |
26.71 |
1,290 |
34,456 |
0 |
| Yang Watkin Phoebe L. | Director |
Sep 30 '26 |
Sale |
26.71 |
1,290 |
34,456 |
24,744 |
| Sitaram Siddharth | Chief Accounting Officer |
Sep 15 '26 |
Sale |
26.02 |
2,077 |
54,044 |
96,045 |
| SIDDHARTH SITARAM | Officer |
Sep 15 '26 |
Proposed Sale |
26.02 |
2,077 |
54,044 |
0 |
| Wampler Kira Scherer | Director |
Sep 01 '26 |
Sale |
26.33 |
2,000 |
52,660 |
27,923 |
| KIRA WAMPLER | Director |
Sep 01 '26 |
Proposed Sale |
26.33 |
2,000 |
52,660 |
0 |
| KIRA WAMPLER | Director |
Aug 25 '26 |
Proposed Sale |
24.95 |
2,000 |
49,900 |
0 |
| Wampler Kira Scherer | Director |
Aug 25 '26 |
Sale |
24.95 |
2,000 |
49,900 |
19,839 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):